SynBioBeta is an organization dedicated to nurturing stable growth of the fledgling synthetic biology industry. We organize partnering conferences, create podcasts, host educational courses, and distribute a regular news digest email to synthetic biology startup companies and others in the industry.

SynBioBeta conferences provide an opportunity to meet the up and coming synthetic biology companies, founders, established players, investors and service providers. You’ll learn about the investment trends and the latest technological advances. You will have the opportunity to talk with Angels and VC’s and find out what they’re looking for in new companies. You can network with like-minded individuals and innovators. Come away from SynBioBeta with a new knowledge of the industry and invaluable connections for the future.

SynBioBeta offers a range of courses, from introductory materials for the non-expert, to investor education and advanced courses in particular techniques. Our introductory course to synthetic biology is designed for people with little or no previous knowledge of biology, but with some background in the shared engineering skill set of creative problem solving. Students get an introduction to the world of biology, biotechnology and synthetic biology.


John Cumbers

John Cumbers


John Cumbers received his PhD in Molecular Biology, Cell Biology, and Biochemistry from Brown University. He has a masters degree in bioinformatics from the University of Edinburgh in Scotland and an undergraduate degree in computer science from the University of Hull in England. He founded the iGEM (International Genetically Engineered Machines competition) team at Brown in 2005, was an iGEM ambassador to China in 2006/2007 and has been working in the field of synthetic biology and resource utilization in space at NASA Ames since 2008.


Kate Wildauer

Executive Director,
Educational Services

Kate Wildauer received her bachelor’s in Business Administration from Villanova University and a Master’s in Microbiology from Thomas Jefferson University. Her 20 years experience includes positions in oncology research, clinical data coordination, project management, training, business development and services director for a non-profit organization. She founded and ran a successful business for 10 years and served as adjunct faculty at Villanova.


Josh Gilmore


Dr. Josh Gilmore received his PhD in Chemistry from University of California Berkeley in 2007 with Matt Francis while studying protein attachment to synthetic surfaces. He performed his postdoctoral work with Professor Jay Keasling at the Joint BioEnergy Institute and SynBERC, learning how synthetic biology can be applied to biofuel production and DNA control mechanisms. He has extensive teaching experience and was a back-to-back outstanding student instructor for organic chemistry at University of California Berkeley. He is currently a consultant for synthetic biology start-up companies.